Viewing Study NCT01441193


Ignite Creation Date: 2025-12-25 @ 1:04 AM
Ignite Modification Date: 2025-12-30 @ 2:57 PM
Study NCT ID: NCT01441193
Status: TERMINATED
Last Update Posted: 2016-03-04
First Post: 2011-09-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I Safety and Immunogenicity Preventive Vaccine Trial Based on the HIV-1 Tat and V2-deleted Env Proteins (ISS P-002)
Sponsor: Barbara Ensoli, MD
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module